Page 100 - Read Online

Page 8 of 9 Lim et al. Vessel Plus 2021;5:34 https://dx.doi.org/10.20517/2574-1209.2021.44

6. Hacke W, Kaste M, Bluhmki E, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. New Engl J Med
2008;359:1317-29. DOI PubMed
7. Emberson J, Lees KR, Lyden P, et al. Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis
with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials. Lancet 2014;384:1929-35.
DOI PubMed PMC
8. Lees KR, Emberson J, Blackwell L, et al. Effects of alteplase for acute stroke on the distribution of functional outcomes. Stroke
2016;47:2373-9. DOI PubMed PMC
9. Astrup J, Symon L, Branston NM, Lassen NA. Cortical evoked potential and extracellular K+ and H+ at critical levels of brain
ischemia. Stroke 1977;8:51-7. DOI PubMed
10. Astrup J, Siesjö BK, Symon L. Thresholds in cerebral ischemia - the ischemic penumbra. Stroke 1981;12:723-5. DOI PubMed
11. Thirugnanachandran T, Ma H, Singhal S, et al. Refining the ischemic penumbra with topography. Int J Stroke 2018;13:277-84. DOI
PubMed
12. Davis S, Donnan GA. Time is penumbra: imaging, selection and outcome. Cerebrovasc Dis 2014;38:59-72. DOI PubMed
13. Markus R, Reutens DC, Kazui S, et al. Hypoxic tissue in ischaemic stroke: persistence and clinical consequences of spontaneous
survival. Brain 2004;127:1427-36. DOI PubMed
14. Kidwell CS, Alger JR, Saver JL. Beyond mismatch: evolving paradigms in imaging the ischemic penumbra with multimodal magnetic
resonance imaging. Stroke 2003;34:2729-35. DOI PubMed
15. Purushotham A, Campbell BCV, Straka M, et al. Apparent diffusion coefficient threshold for delineation of ischemic core. Int J Stroke
2015;10:348-53. DOI PubMed PMC
16. Olivot JM, Mlynash M, Thijs VN, et al. Optimal Tmax threshold for predicting penumbral tissue in acute stroke. Stroke 2009;40:469-
75. DOI PubMed PMC
17. Ma HK, Zavala JA, Churilov L, et al. The hidden mismatch: an explanation for infarct growth without perfusion-weighted
imaging/diffusion-weighted imaging mismatch in patients with acute ischemic stroke. Stroke 2011;42:662-8. DOI PubMed
18. Ma H, Zavala JA, Teoh H, et al. Penumbral mismatch is underestimated using standard volumetric methods and this is exacerbated
with time. J Neurol Neurosurg Psychiatry 2009;80:991-6. DOI PubMed
19. Campbell BC, Christensen S, Levi CR, et al. Comparison of computed tomography perfusion and magnetic resonance imaging
perfusion-diffusion mismatch in ischemic stroke. Stroke 2012;43:2648-53. DOI PubMed
20. Wintermark M, Reichhart M, Cuisenaire O, et al. Comparison of admission perfusion computed tomography and qualitative diffusion-
and perfusion-weighted magnetic resonance imaging in acute stroke patients. Stroke 2002;33:2025-31. DOI PubMed
21. Davis SM, Donnan GA, Parsons MW, et al. Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic
Evaluation Trial (EPITHET): a placebo-controlled randomised trial. Lancet Neurol 2008;7:299-309. DOI PubMed
22. Albers GW, Thijs VN, Wechsler L, et al; DEFUSE Investigators. Magnetic resonance imaging profiles predict clinical response to
early reperfusion: the diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study. Ann Neurol
2006;60:508-17. DOI PubMed
23. Picanço MR, Christensen S, Campbell BC, et al. Reperfusion after 4.5 hours reduces infarct growth and improves clinical outcomes.
Int J Stroke 2014;9:266-9. DOI PubMed
24. Ogata T, Christensen S, Nagakane Y, et al. The effects of alteplase 3 to 6 hours after stroke in the EPITHET-DEFUSE combined
dataset. Stroke 2013;44:87-93. DOI PubMed
25. Albers GW, von Kummer R, Truelsen T, et al. Safety and efficacy of desmoteplase given 3-9 h after ischaemic stroke in patients with
occlusion or high-grade stenosis in major cerebral arteries (DIAS-3): a double-blind, randomised, placebo-controlled phase 3 trial.
Lancet Neurol 2015;14:575-84. DOI PubMed
26. Campbell BC, Christensen S, Foster SJ, et al; EPITHET Investigators. Visual assessment of perfusion-diffusion mismatch is
inadequate to select patients for thrombolysis. Cerebrovasc Dis 2010;29:592-6. DOI PubMed
27. Campbell BC, Parsons MW. Imaging selection for acute stroke intervention. Int J Stroke 2018;13:554-67. DOI PubMed
28. Campbell BC, Yassi N, Ma H, et al. Imaging selection in ischemic stroke: feasibility of automated CT-perfusion analysis. Int J Stroke
2015;10:51-4. DOI PubMed
29. Ma H, Parsons MW, Christensen S, et al. A multicentre, randomized, double-blinded, placebo-controlled Phase III study to investigate
EXtending the time for Thrombolysis in Emergency Neurological Deficits (EXTEND). Int J Stroke 2012;7:74-80. DOI PubMed
30. Thomalla G, Fiebach JB, Østergaard L, et al. A multicenter, randomized, double-blind, placebo-controlled trial to test efficacy and
safety of magnetic resonance imaging-based thrombolysis in wake-up stroke (WAKE-UP). Int J Stroke 2014;9:829-36. DOI PubMed
31. Thomalla G, Gerloff C. Acute imaging for evidence-based treatment of ischemic stroke. Curr Opin Neurol 2019;32:521-9. DOI
PubMed
32. Koga M, Yamamoto H, Inoue M, et al; THAWS Trial Investigators. Thrombolysis with alteplase at 0.6 mg/kg for stroke with
unknown time of onset. Stroke 2020;51:1530-8. DOI PubMed PMC
33. Ringleb P, Bendszus M, Bluhmki E, et al. Extending the time window for intravenous thrombolysis in acute ischemic stroke using
magnetic resonance imaging-based patient selection. Int J Stroke 2019;14:483-90. DOI PubMed
34. Schwamm LH, Wu O, Song SS, et al. Intravenous thrombolysis in unwitnessed stroke onset: MR WITNESS trial results. Ann Neurol
2018;83:980-93. DOI PubMed PMC
35. Campbell BC, Ma H, Ringleb PA, et al; EXTEND; ECASS-4; and EPITHET Investigators. Extending thrombolysis to 4.5-9 h and
wake-up stroke using perfusion imaging: a systematic review and meta-analysis of individual patient data. Lancet 2019;394:139-47.
DOI PubMed